Cluster 32: agents investigational receiving patients subjects ineligible patient treatment days registration 
Cluster 494: current use malignancy treatment history diagnosis study disease planned prior 
Cluster 915: agents investigational weeks use study treatment days prior current receiving 
Cluster 1494: statin use current therapy donor pbsc months treatment drugs pravastatin 
Cluster 2241: concurrently investigational receiving agents study patients drug days treatment participation 
Cluster 2353: medication immunosuppressive prior use current days dose systemic treatment exceptions 
